Light Mode
$6.12 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.12, and at the day’s high of $6.12
-0.38 (-5.85%) / 6M
Momentum, market sentiment, and recent alerts
EKTAF reads n/a: the 12-month move is +2.0%.
No alerts for EKTAF in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: Americas, EMEA, APAC, and Others. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.
| Ticker | Company | Price | Change |
|---|---|---|---|
| FSNUY | Fresenius SE & Co. KGaA Sponsored ADR | $14.86 | +2.34% |
| SRTOY | Sartorius Stedim Biotech SA Unsponsored ADR | $25.67 | +1.06% |
| FSPKF | Fisher & Paykel Healthcare Corporation Limited | $26.99 | -0.07% |
| HSIC | Henry Schein, Inc. | $88.41 | +2.74% |
| EKTAY | Elekta AB Unsponsored ADR Class B | $6.02 | -2.27% |
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.